Apellis Pharmaceuticals, Inc. Insider Transactions
Apellis Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Baumal Caroline
Chief Medical Officer |
Sell | 2,816 @ $33.81 | $95,215 | 55,560 | 01/06/2025 | 01/08/2025 | |
|
Eisele Jeffrey
Chief Development Officer |
Sell | 63 @ $33.09 | $2,085 | 57,145 | 12/23/2024 | 12/27/2024 | |
|
Watson David O.
General Counsel |
Sell | 5,000 @ $34.24 | $171,175 | 112,721 | 12/11/2024 | 12/13/2024 | |
|
Dunlop A. Sinclair
Director |
Sell | 29,476 @ $36.09 | $1.06 M | 107,524 | 09/16/2024 | 09/17/2024 | |
|
Dunlop A. Sinclair
Director |
Sell | 7,524 @ $36.79 | $276,808 | 100,000 | 09/16/2024 | 09/17/2024 | |
|
Chopas James George
VP/CAO |
Sell | 192 @ $36.21 | $6,952 | 38,141 | 09/16/2024 | 09/17/2024 | |
|
Chopas James George
VP/CAO |
Sell | 550 @ $39.49 | $21,720 | 38,333 | 09/03/2024 | 09/04/2024 | |
|
Dunlop A. Sinclair
Director |
Sell | 35,305 @ $39.22 | $1.38 M | 138,693 | 06/21/2024 | 06/21/2024 | |
|
Dunlop A. Sinclair
Director |
Sell | 1,695 @ $39.63 | $67,173 | 136,998 | 06/21/2024 | 06/21/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 56,335 @ $42.15 | $2.37 M | 1,138,555 | 05/08/2024 | 05/09/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 22,472 @ $42.85 | $962,903 | 1,116,083 | 05/08/2024 | 05/09/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 100 @ $44.03 | $4,403 | 1,115,983 | 05/08/2024 | 05/09/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 4,728 @ $54.92 | $259,639 | 1,115,983 | 04/08/2024 | 04/09/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 64,379 @ $54.12 | $3.48 M | 1,120,711 | 04/08/2024 | 04/09/2024 | |
| Sell | 4,000 @ $58.66 | $234,640 | 93,338 | 04/01/2024 | 04/02/2024 | ||
|
Dunlop A. Sinclair
Director |
Sell | 18,681 @ $57.18 | $1.07 M | 173,998 | 03/19/2024 | 03/20/2024 | |
|
DeLong Mark Jeffrey
Chief Business & Strat Officer |
Sell | 9,913 @ $56.90 | $564,050 | 54,693 | 03/18/2024 | 03/19/2024 | |
|
Chopas James George
VP/CAO |
Sell | 184 @ $56.46 | $10,389 | 38,883 | 03/15/2024 | 03/18/2024 | |
|
Nicholson Nur
Chief Technical Officer |
Sell | 7,768 @ $57.31 | $445,161 | 59,739 | 03/13/2024 | 03/14/2024 | |
|
Nicholson Nur
Chief Technical Officer |
Sell | 3,452 @ $58.13 | $200,677 | 56,287 | 03/13/2024 | 03/14/2024 |
Apellis Pharmaceuticals, Inc. FAQ's
Who is on Apellis Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Apellis Pharmaceuticals, Inc. includes Eisele Jeffrey, Lewis Karen, Watson David O., DeLong Mark Jeffrey, Nicholson Nur, Deschatelets Pascal, Sullivan Timothy Eugene, Francois Cedric, Townsend Adam J., Chopas James George, Dunlop A. Sinclair, Baumal Caroline.
How much insider selling is happening at Apellis Pharmaceuticals, Inc.?
Insiders have sold a total of 630,608 Apellis Pharmaceuticals, Inc. shares in the last 12 months for a total of 35.41 M sold.
Which Apellis Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Apellis Pharmaceuticals, Inc. shares in the last 12 months: Eisele Jeffrey ($553,514), Lewis Karen ($354,377), Watson David O. ($282,210), DeLong Mark Jeffrey ($628,045), Nicholson Nur ($699,393), Deschatelets Pascal ($11.52 M), Sullivan Timothy Eugene ($769,064), Francois Cedric ($16.48 M), Townsend Adam J. ($135,906), Chopas James George ($39,060), Dunlop A. Sinclair ($3.86 M), Baumal Caroline ($95,215),